Evidence map›Paper›PMID 32462287›Full record

ArticleInfection2020

Extended-spectrum beta-lactamase (ESBL) producing Enterobacterales in stool surveillance cultures of preterm infants are no risk factor for necrotizing enterocolitis: a retrospective case-control study over 12 years.

Martin Eberhart, Andrea Grisold, Michela Lavorato, Elisabeth Resch, Andreas Trobisch, Bernhard Resch

Open access · hybridAbstract read
In one paragraph

Article in Infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. The role of Klebsiella populations in preterm infants.Biochemical Society transactions · 2023
    Review
  3. Article
  4. Intestinal colonization with ESBL-producingFrontiers in public health · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Martin EberhartResearch Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria.
Andrea GrisoldD&R Institute of Hygiene Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Michela LavoratoResearch Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria.
Elisabeth ReschResearch Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria.
Andreas TrobischResearch Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria.
Bernhard ReschResearch Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria. Bernhard.resch@medunigraz.at.ORCID http://orcid.org/0000-0003-4348-8299
Medical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMicrobial dysbiosis has been found preceding necrotizing enterocolitis (NEC) in preterm infants; thus, we aimed to investigate whether there is evidence that neonates with extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) positive stool cultures are at higher risk for NEC at the NICU.

methodsWe included very preterm inborn infants of ≤ 32 weeks of gestational age being fecal carriers of ESBL-E and compared them with 1:1 matched (gestational age, birth weight, gender and year) controls tested negative for ESBL-E in the stool between 2005 and 2016. An association with NEC was defined as the first detection of ESBL-E before or at the time of definite diagnosis of NEC.

resultsDuring the study period, we diagnosed 217 infants with a total of 270 ESBL-E. We identified ten different species with ESBL-producing Klebsiella oxytoca being the most common one (46%) followed by Klebsiella pneumoniae (19%), and Citrobacter freundii (17%). Ten out of 217 infants had any kind of NEC in the case group compared to two of the controls (p < 0.01), but only four cases with predefined criteria were associated with NEC ≥ stage IIa (1.8 vs. 0.5%, p = 0.089, OR 4.1, CI95% 0.45-36.6). NEC mortality rate was 2/8 (25%).

conclusionsWe observed a threefold increase of ESBL-E in stool surveillance cultures during study time and germs were dominated by ESBL-producing Klebsiella spp. There was no evidence that preterm infants colonized with ESBL-E in the stool were at higher risk for definite NEC.

Indexed as

Austriabeta-LactamasesCase-Control StudiesEnterobacteriaceaeEnterobacteriaceae InfectionsEnterocolitis, NecrotizingFecesFemaleHumansIncidenceInfant, NewbornInfant, PrematureIntensive Care Units, NeonatalMaleRetrospective StudiesRisk Factorsbeta-LactamasesEnterobacteralesEpidemiologyESBLNecrotizing enterocolitisPreterm infantRisk

Identifiers

PMID32462287
PMCPMC7674344
OpenAlexW3030526294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.